Yongkun Wei

14.3k citations

56 papers · 7.6k indexed · 5 hit papers · h-index 35

Impact in

Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy

Papers in

Oncology 29
- Cancer-related Molecular Pathways 11
- HER2/EGFR in Cancer Research 6
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 4
Cancer Research 10
- Cancer-related molecular mechanisms research 4

Co-authors: Mien‐Chie Hung Weiya Xia Gabriel N. Hortobágyi Hui‐Wen Lo Mohamed Ali‐Seyed Dihua Yu Jung-Mao Hsu Jennifer L. Hsu
Journals: Cancer Research (12 papers)Cancer Cell (5 papers)Nature Cell Biology (4 papers)Molecular Carcinogenesis (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United States Taiwan China

In The Last Decade

Yongkun Wei

55 papers receiving 7.6k citations

Hit Papers

5 papers align trajectories log scale

TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis 2021 · 255 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of Clinical Investigation
2020 Nature
2018 Nature Cell Biology
2017 Clinical Cancer Research
2007 Cancer Research

Peers

Countries citing papers authored by Yongkun Wei

Since Specialization

Citations

This map shows the geographic impact of Yongkun Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongkun Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongkun Wei more than expected).

Fields of papers citing papers by Yongkun Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongkun Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongkun Wei. The network helps show where Yongkun Wei may publish in the future.

Co-authors

The 25 scholars most cited alongside Yongkun Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yongkun Wei Line = papers co-authored together Yongkun Wei links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function Cancer Research ·Xixi Zhao, Yongkun Wei, Yu‐Yi Chu, Yintao Li, Jung-Mao Hsu, Zhou Jiang, Chunxiao Liu, Jennifer L. Hsu, Wei‐Chao Chang, Ri‐Yao Yang, Li-Chuan Chan, Jingkun Qu, Shuqun Zhang, Haoqiang Ying, Dihua Yu, Mien‐Chie Hung	2022	36
2	An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response STAR Protocols ·Ying‐Nai Wang, Heng‐Huan Lee, Yongkun Wei, Yu‐Yi Chu, Weiya Xia, Michael Wang, Dihua Yu, Mien‐Chie Hung	2022	5
3	TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis Journal of Clinical Investigation ·Zhou Jiang, Seung-Oe Lim, Meisi Yan, Jennifer L. Hsu, Jun Yao, Yongkun Wei, Sam S. Chang, Hirohito Yamaguchi, Heng‐Huan Lee, Baozhen Ke, Jung-Mao Hsu, Li-Chuan Chan, Gabriel N. Hortobágyi, Liuqing Yang, Chunru Lin, Dihua Yu, Mien‐Chie Hung Hit paper breakdown →	2021	255
4	Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer Oncogene ·Yufan Qiu, صباح حسنی, Ri‐Yao Yang, Chunxiao Liu, Jung-Mao Hsu, Zhou Jiang, Linlin Sun, Yongkun Wei, Chia‐Wei Li, Dihua Yu, Jin Zhang, Mien‐Chie Hung	2021	112
5	The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis Nature ·Daqian Xu, Zheng Wang, Yan Xia, Fei Shao, Weiya Xia, Yongkun Wei, Xinjian Li, Xu Qian, Jong-Ho Lee, Linyong Du, Yanhua Zheng, Guishuai Lv, Jia-Shiun Leu, Hongyang Wang, Dongming Xing, Tingbo Liang, Mien‐Chie Hung, Zhimin Lu Hit paper breakdown →	2020	260
6	Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy Cancer Cell ·Heng‐Huan Lee, Ying‐Nai Wang, Weiya Xia, Chia‐Hung Chen, Kun-Ming Rau, Leiguang Ye, Yongkun Wei, Chao‐Kai Chou, Shao‐Chun Wang, Meisi Yan, Chih‐Yen Tu, Te‐Chun Hsia, Shu‐Fen Chiang, K. S. Clifford Chao, Ignacio I. Wistuba, Jennifer L. Hsu, Gabriel N. Hortobágyi, Mien‐Chie Hung	2019	282
7	EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma Cancer Research ·Qiongzhu Dong, Yi Du, Hui Li, Chunxiao Liu, Yongkun Wei, Mei‐Kuang Chen, Xixi Zhao, Yu‐Yi Chu, Yufan Qiu, Lun–Xiu Qin, Hirohito Yamaguchi, Mien‐Chie Hung	2018	59
8	PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression Clinical Cancer Research ·Shiping Jiao, Weiya Xia, Hirohito Yamaguchi, Yongkun Wei, Mei‐Kuang Chen, Jung-Mao Hsu, Jennifer L. Hsu, Wen-Hsuan Yu, Yi Du, Heng‐Huan Lee, Chia‐Wei Li, Chao‐Kai Chou, Seung-Oe Lim, Sam S. Chang, Jennifer K. Litton, Banu Arun, Gabriel N. Hortobágyi, Mien‐Chie Hung Hit paper breakdown →	2017	768
9	JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis Cancer Research ·Na Li, Shilpa S. Dhar, Tsai‐Yu Chen, Prof. Anshul Mathur, Yongkun Wei, Jae-Hwan Kim, Chia‐Hsin Chan, Hui‐Kuan Lin, Mien‐Chie Hung, Min Gyu Lee	2016	101
10	Aberrant Expression of proPTPRN2 in Cancer Cells Confers Resistance to Apoptosis Cancer Research ·Alexey V. Sorokin, Binoj C. Nair, Yongkun Wei, Kathryn E. Aziz, Valentina Evdokimova, Mien‐Chie Hung, Junjie Chen	2015	21
11	S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer. PubMed Central ·Yekaterina B. Khotskaya, Justus Kirimi, Jia Shen, Mariano Ponz‐Sarvisé, and M. Hasegawa, Ming‐Chuan Hsu, Yongkun Wei, Weiya Xia, Dihua Yu, Mien‐Chie Hung	2014	38
12	lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals Cell ·Zhen Xing, Aifu Lin, Chunlai Li, Ke Liang, Shouyu Wang, Yang Liu, Peter K. Park, Li Qin, Yongkun Wei, David H. Hawke, Mien‐Chie Hung, Chunru Lin, Liuqing Yang	2014	346
13	ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1 Nature Cell Biology ·Peijing Zhang, Yongkun Wei, ΕΥΑΓΓΕΛΟΣ ΜΟΥΤΖΟΥΚΗΣ, Bisrat G. Debeb, Yuan Yuan, Jinsong Zhang, Jingsong Yuan, Min Wang, Dahu Chen, Yutong Sun, Wendy A. Woodward, Yongqing Liu, Douglas C. Dean, Han Liang, Ye Hu, K. Kian Ang, Mien‐Chie Hung, Junjie Chen, Li Ma	2014	355
14	KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling Journal of Clinical Investigation ·Klaus W. Wagner, Hunain Alam, Shilpa S. Dhar, Uma Giri, Na Li, Yongkun Wei, Dipak Kumar Giri, Tina Cascone, Karla Beg, Yuanqing Ye, Asha S. Multani, Chia‐Hsin Chan, Baruch Erez, Babita Saigal, Jeong won 최정원Choi, Hui-Kuan Lin, Xifeng Wu, Mien‐Chie Hung, John V. Heymach, Min Gyu Lee	2013	149
15	Deubiquitylation and stabilization of PTEN by USP13 Nature Cell Biology ·Jinsong Zhang, Peijing Zhang, Yongkun Wei, Hai-long Piao, Wenqi Wang, Subbareddy Maddika, Min Wang, Dahu Chen, Yutong Sun, Mien‐Chie Hung, Junjie Chen, Li Ma	2013	173
16	LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker Nature Medicine ·Dahu Chen, Yutong Sun, Yongkun Wei, Peijing Zhang, Abdol Hossein Rezaeian, Julie Teruya‐Feldstein, Sumeet Gupta, Han Liang, Hui‐Kuan Lin, Mien‐Chie Hung, Li Ma	2012	352
17	TNFα induces HIF-1α expression through activation of IKKβ Biochemical and Biophysical Research Communications ·Hsu-Ping Kuo, Dung‐Fang Lee, Weiya Xia, Yongkun Wei, Mien‐Chie Hung	2009	25
18	Bile Acid Exposure Up-regulates Tuberous Sclerosis Complex 1/Mammalian Target of Rapamycin Pathway in Barrett's-Associated Esophageal Adenocarcinoma Cancer Research ·Chia-Jui Yen, Julie Izzo, Dung‐Fang Lee, Sushovan Guha, Yongkun Wei, Tsung‐Teh Wu, Chun‐Te Chen, Hsu-Ping Kuo, Jung-Mao Hsu, Hui-Lung Sun, Chao‐Kai Chou, Navtej Buttar, Kenneth K. Wang, Peng Huang, Jaffer A. Ajani, Mien‐Chie Hung	2008	49
19	Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer Cancer Research ·Qingqing Ding, Longfei Huo, Jer-Yen Yang, Weiya Xia, Yongkun Wei, Yong Liao, Chun–Ju Chang, Yan Yang, Chien‐Chen Lai, Dung‐Fang Lee, Chia-Jui Yen, Babak Mirin Babazadeghan, Jung-Mao Hsu, Hsu-Ping Kuo, Chun-Yi Lin, Fuu‐Jen Tsai, Long‐Yuan Li, Chang‐Hai Tsai, Mien‐Chie Hung	2008	163
20	GSK-3β Targets Cdc25A for Ubiquitin-Mediated Proteolysis, and GSK-3β Inactivation Correlates with Cdc25A Overproduction in Human Cancers Cancer Cell ·Tiebang Kang, Yongkun Wei, Yuchi Honaker, Hiroshi Yamaguchi, Ettore Appella, Mien‐Chie Hung, Helen Piwnica‐Worms	2008	131

About Yongkun Wei

Yongkun Wei is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 7.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Epigenetics and DNA Methylation (11 papers), RNA modifications and cancer (7 papers), HER2/EGFR in Cancer Research (6 papers), Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (2.2k citations), Oncology (3.3k citations), Molecular Biology (4.9k citations), Immunology (1.2k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Yongkun Wei has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Mien‐Chie Hung, Weiya Xia, Gabriel N. Hortobágyi, Hui‐Wen Lo, Mohamed Ali‐Seyed, Dihua Yu, Jung-Mao Hsu, Jennifer L. Hsu, James L. Abbruzzese and Junjie Chen. Their work appears in journals such as Cancer Research, Cancer Cell, Nature Cell Biology, Molecular Carcinogenesis and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact